BPMC - Blueprint Medicines Corp
IEX Last Trade
95.37
1.760 1.845%
Share volume: 307,148
Last Updated: Fri 30 Aug 2024 10:00:00 PM CEST
Research and Development in Biotechnology (except Nanobiotechnology):
0.21%
PREVIOUS CLOSE
CHG
CHG%
$93.61
1.76
1.88%
Summary score
9%
Profitability
0%
Dept financing
18%
Liquidity
67%
Performance
1%
Sector
Professional, Scientific, and Technical Services
Industry
Research and Development in Biotechnology (except Nanobiotechnology)
Long-term ratios 30-Jun-2020 - 30-Jun-2024
The data are presented for the financials results of the quarters of the last 4 years.
Return on equity
-19.51%
Return on assets
-6.62%
Return on sales
-241.2%
Return on invested capital
-81.48%
Total debt ratio
45.36%
Debt ratio change over timeo
-1.55%
Current Ratio
5.49%
Quick Ratio
5.36%
Cash Position Ratio
4.81%
Short-term ratios 30-Jun-2023 - 30-Jun-2024
The data are presented for the financials results of the quarters of the last year.
Return on equity
-34.46%
Return on assets
-8.17%
Return on sales
-121.05%
Return on invested capital
-122.35%
Total debt ratio
78.17%
Debt ratio change over timeo
-1.26%
Current Ratio
3.83%
Quick Ratio
3.73%
Cash Position Ratio
3.3%
Last quarter ratios 30-Jun-2024
The data are presented for the financials results of the last quarter.
Return on equity
-15.61%
Return on assets
-3.58%
Return on sales
-31.16%
Return on invested capital
-88.94%
Total debt ratio
73.39%
Debt ratio change over time
-1.83%
Current Ratio
3.71%
Quick Ratio
3.65%
Cash Position Ratio
3.13%
Performance ratios (change over 4 years) 30-Jun-2020 - 30-Jun-2024
The data are presented for the change financials results of the quarter of the last 4 years.
Return on equity
-72.68%
Return on assets
-81.24%
Return on sales
703.02%
Return on invested capital
-32.88%
Total debt ratio
-154.64%
Debt ratio change over time
-1.55%
Current Ratio
-15.85%
Quick Ratio
-15.56%
Cash Position Ratio
-14.48%
Compare in sector
The following table compares the individual analyzes for the other top 3 stocks within the same industry.
| Long-term ratios | BPMC | ABBV | AMGN | REGN |
|---|---|---|---|---|
| Return on equity | -19.51% | 15.05% | 35.64% | 7.13% |
| Return on assets | -6.62% | 2.88% | 3.13% | 5.53% |
| Return on sales | -241.2% | 29.62% | 32.25% | 40.49% |
| Return on invested capital | -81.48% | 2.57% | 5.37% | 18.48% |
| Profitability | 0% | 45% | 66% | 80% |
| Total debt ratio | 45.36% | 90.48% | 91% | 25.78% |
| Debt ratio change over time | -1.55% | 326.95% | -8.44% | 1.18% |
| Dept financing | 12% | 50% | 25% | 7% |
| Current Ratio | 3.83% | 0.92% | 1.98% | 5.39% |
| Quick Ratio | 3.73% | 0.81% | 1.56% | 4.63% |
| Cash Position Ratio | 3.3% | 0.39% | 1.05% | 2.91% |
| Liquididy | 75% | 9% | 21% | 51% |
| Short-term ratios | BPMC | ABBV | AMGN | REGN |
|---|---|---|---|---|
| Return on equity | -34.46% | 13.14% | 10.88% | 4.07% |
| Return on assets | -8.17% | 2.1% | 1.54% | 3.03% |
| Return on sales | -121.05% | 21.74% | 18.43% | 30.26% |
| Return on invested capital | -122.35% | 1.95% | 2.74% | 9.55% |
| Profitability | 0% | 65% | 56% | 83% |
| Total debt ratio | 78.17% | 92.68% | 93.24% | 21.84% |
| Debt ratio change over time | -1.26% | 51.04% | -101.54% | 1.43% |
| Dept financing | 21% | 50% | 25% | 7% |
| Current Ratio | 3.83% | 0.92% | 1.98% | 5.39% |
| Quick Ratio | 3.73% | 0.81% | 1.56% | 4.63% |
| Cash Position Ratio | 3.3% | 0.39% | 1.05% | 2.91% |
| Liquididy | 63% | 12% | 26% | 72% |